Intersect ENT Receives $30,000,000 Series C Financing
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=82249051-73d6-493b-b231-d55d45ec7398&Preview=1 -
Date
11/2/2010 -
Company Name
Intersect ENT -
Mailing Address
1049 Elwell Court Palo Alto, CA 94303 -
Company Description
Intersect ENT Inc. (formerly Sinexus) is a medical device company pioneering novel therapies for Ear, Nose & Throat surgeons to utilize in providing improved treatment for their patients. -
Website
http://www.intersectent.com -
Transaction Type
Venture Equity -
Transaction Amount
$30,000,000 -
Transaction Round
Series C -
Proceeds Purposes
Intersect ENT intends to use the proceeds to commercialize its initial product as well as build a portfolio of products for conditions treated by Ear, Nose, & Throat (ENT) surgeons. -
M&A Terms
-
Venture Investor
Medtronic -
Venture Investor
PTV Sciences -
Venture Investor
Kleiner Perkins Caufield & Byers -
Venture Investor
U.S. Venture Partners
